Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score

<div>PFS (a) and OS (b) according to LIPI groups of patients with advanced BTC treated with the ICIs in subsequent lines. PFS: progression-free survival; OS: overall survival; LIPI: lung immune prognostic index; BTC: biliary tract cancer; ICIs: immune checkpoint inhibitors.</div>

Journal of Oncology

fig4

Figure 4

Figure 4: Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score 

Figure 4 | Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score 